PT - JOURNAL ARTICLE AU - Peter de Man AU - Marco Ortiz AU - Philomena M. Bluyssen AU - Stijn J. de Man AU - Marie-Jozé Rentmeester AU - Marijke van der Vliet AU - Evert-Jan Wils AU - David S.Y. Ong TI - Exposition to airborne SARS-CoV-2 in household and hospitals settings as studied by a vacuum cleaner as a high-powered air sampler AID - 10.1101/2021.07.16.21260337 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.16.21260337 4099 - http://medrxiv.org/content/early/2021/07/19/2021.07.16.21260337.short 4100 - http://medrxiv.org/content/early/2021/07/19/2021.07.16.21260337.full AB - Background We aimed to study the presence of SARS-CoV-2 in air surrounding infected healthcare workers (HCW) in their homes versus infected patients who were undergoing potential aerosol-generating medical procedures (AGMP). We also studied the effect of different face masks worn bij infected persons on spread of SARS-CoV-2 into the air.Methods We developed a high-volume air sampler method that uses a household vacuum cleaner with a surgical mask serving as a sample filter. SARS-CoV-2 RNA was harvested from these sample filters and analyzed on the presence of RNA by polymerase chain reaction. We acquired air samples in close aproximity of HCWs wearing different facemasks. Also, we obtained free air samples away from the infected HCWs and samples near intensive care unit (ICU) patients undergoing AGMP. Fog experiments were performed to visualize the airflow around our air sampler.Results Aerosols were visibly suctioned into the vacuum cleaner when there was no face mask, whereas wearing a face mask resulted in a delayed and reduced flow of aerosols into the vacuum cleaner. The face masks that were worn by the HCWs were positive in 54-83% of cases. The proportion of positive air samples was higher in household settings of recently infected HCWs (29/41; 70.7%) compared to ICU settings (4/17; 23.5%) (p<0.01).Conclusion This high-volume air sampler method was able to detect SARS-CoV-2 RNA in air samples. Air samples in the household environment of recently infected HCWs more frequently contained SARS-CoV-2 in comparison to those obtained in patient rooms during potential AGMP.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the Franciscus Gasthuis and Vlietland Hospital in Rotterdam approved the study protocol and ethical approval was obtained (IRB protocol number 2020-092).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request.